2011 RAPS Planning Committee

Chair
Cecilia Kimberlin, PhD, RAC, FRAPS, vice president, AQR strategic deployment, QA/RA/MA, Abbott Laboratories

Members

Mehrshid Alai-Safar, PhD, senior director, global regulatory affairs, Baxter Healthcare Corporation
Daniel (Dan) Biank, ME, JD, RAC, manager, risk management, GE Healthcare
Gert W. Bos, PhD, head of regulatory and clinical affairs, BSI Group
Linda Bowen, MS, RAC, FRAPS, regulatory policy and intelligence, global regulatory affairs, Sanofi-Aventis
Laura Byrd, MS, electrical engineer, CDRH, US FDA
Todd Chermak, RPh, PhD, divisional vice president of regulatory affairs PPG, CMC and business planning, Abbott Laboratories
Bernard (Bernie) Chiasson, PhD, vice president, US strategic regulatory services and medical services, OptumInsight.
Leslie Lake Curry, director, regulatory affairs, Abbott Nutrition, Abbott Laboratories
Mark Gordon, RAC, FRAPS, vice president, global regulatory and clinical affairs, Synthes
Steven Hoff, PhD, RAC, professor, Department of Pharmacy Practice, College of Pharmacy, Rosalind Franklin University of Medicine and Science
Rebecca (Becky) Hoffman, MD, divisional vice president, medical affairs, Abbott Quality & Regulatory, Abbott
Joel Kent, MS, RAC, manager, quality and regulatory affairs, GE Healthcare
Kyenghee Kwon, PhD, vice president, Korean Society of Pharmaceutical Regulatory Sciences
Wendy Z. Lambert, director, pharma business support, Abbott Quality & Regulatory
Daniel (Dan) Mannix, PhD, group director, global regulatory strategy, Bristol Myers Squibb Co.
John Manthei, JD, partner, Latham & Watkins
Prem K. (PK) Narang, PhD, FCP, former head, global regulatory affairs, medical diagnostics, GE Healthcare-MDX
James (Jim) O'Reilly, professor of law, University of Cincinnati
Maruthi Prasad Palthur, MPharm, RAC, senior director, technical operations & regulatory affairs, Indigene Pharmaceuticals Inc.
Manfred Ruthsatz, PhD, RPh, DABT, RAC, head global regulatory affairs & reimbursement, Nestlé HealthCare Nutrition
Patricia (Pat) Scaman, former divisional vice president, Abbott Nutrition Regulatory Affairs, Abbott Laboratories
Robert (Bob) Schiff, PhD, RAC, CQA, FRAPS, president and CEO, Schiff & Company, Inc.
Raymond Seda, MBA, RAC, regulatory affairs manager, Zimmer Inc.
Nancy Singer, JD, LLM, RAC, FRAPS, president, Compliance-Alliance
Usha Srinivasan, MS, RAC, manager, R&D operations, Marcadia Biotech
Dane Stout, executive director, connected health practice, Anson Group LLC
Kyoichi Tadano, PhD, director, International Affairs Division, Office of Planning and Coordination, Pharmaceuticals and Medical Devices Agency (PMDA)
Reed Tarwater, PhD, director of pharmaceutical services, The Anson Group
Laurence (Larry) Wallman, RAC (US, EU, CAN), director, regulatory and compliance, DS InPharmatics
Chang-Hong Whitney, MBA, RAC, president, Whitney Consulting Ltd